Use access key #2 to skip to page content.
$3.46 -0.19 (-5.21%)
5/16/2008 3:41 PM

XTENT, Inc. (XTNT)

CAPS Rating:
*

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View All Commentary (XTNT)

Recs

0

Avatar KamranatUCLA (71.71) Submitted: 4/08/08 7:49 AM : Outperform Start Price: $6.23 XTNT Score: -49.17

make money and help sick people doing so...what else do u want bich?

Report this Post Replies: 0 | Reply

Featured Broker Partners